We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.37%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.28B
AUM Growth
-$1.41B
Cap. Flow
-$1.19B
Cap. Flow %
-22.61%
Top 10 Hldgs %
53.54%
Holding
466
New
23
Increased
24
Reduced
24
Closed
360

Top Buys

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$72.5M
2
LEGN icon
Legend Biotech
LEGN
+$64.3M
3
OSCR icon
Oscar Health
OSCR
+$64.1M
4
DVAX
Dynavax Technologies
DVAX
+$62.6M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$39M

Top Sells

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$187M
2
KURA icon
Kura Oncology
KURA
+$106M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$66.5M
4
SGRY icon
Surgery Partners
SGRY
+$57.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 87.97%
2 Industrials 0.23%
3 Consumer Staples 0.01%
4 Energy 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QSIAW
76
DELISTED
Quantum-Si Inc Warrant
QSIAW
$417K 0.01%
333,333
– –
HUM icon
77
Humana
HUM
$45.8B
$233K ﹤0.01%
+917
New +$246K
GIS icon
78
General Mills
GIS
$19.5B
$220K ﹤0.01%
+3,455
New +$232K
ENLC
79
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$145K ﹤0.01%
+10,257
New +$153K
HNST icon
80
The Honest Company
HNST
$423M
$140K ﹤0.01%
20,171
-177,585
-90% -$1.01M
EBS icon
81
Emergent Biosolutions
EBS
$378M
$134K ﹤0.01%
14,058
-61,584
-81% -$565K
HTLD icon
82
Heartland Express
HTLD
$1.06B
$130K ﹤0.01%
11,547
-56,281
-83% -$662K
UIS icon
83
Unisys
UIS
$245M
$98.9K ﹤0.01%
+15,627
New +$109K
BFLY.WS
84
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$93.2K ﹤0.01%
733,333
– –
EGY icon
85
Vaalco Energy
EGY
$552M
$91.3K ﹤0.01%
+20,897
New +$111K
HBI
86
DELISTED
Hanesbrands
HBI
$86.4K ﹤0.01%
10,619
-72,619
-87% -$572K
GNW icon
87
Genworth Financial
GNW
$3.79B
$79K ﹤0.01%
11,307
-36,686
-76% -$263K
ECVT icon
88
Ecovyst
ECVT
$1.34B
$78.8K ﹤0.01%
+10,317
New +$76.2K
CERS icon
89
Cerus
CERS
$615M
$77.5K ﹤0.01%
+50,305
New +$86.5K
EQC
90
DELISTED
Equity Commonwealth
EQC
$76.6K ﹤0.01%
+43,258
New +$666K
ACCO icon
91
Acco Brands
ACCO
$381M
$76.4K ﹤0.01%
14,557
-89,348
-86% -$496K
OSUR icon
92
OraSure Technologies
OSUR
$273M
$75.4K ﹤0.01%
20,898
-140,914
-87% -$561K
NUS icon
93
Nu Skin
NUS
$250M
$70.2K ﹤0.01%
10,194
-126,951
-93% -$873K
GDRX icon
94
GoodRx Holdings
GDRX
$1.03B
$55.8K ﹤0.01%
+11,990
New +$65.9K
NUVB icon
95
Nuvation Bio
NUVB
$2.32B
$53.6K ﹤0.01%
+20,166
New +$51.9K
BRCC icon
96
BRC Inc
BRCC
$116M
$47.6K ﹤0.01%
+15,029
New +$47K
NUVB.WS
97
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$38.3K ﹤0.01%
166,666
– –
DHC
98
Diversified Healthcare Trust
DHC
$2.28B
$36.4K ﹤0.01%
+15,845
New +$46.6K
TOIIW
99
The Oncology Institute Warrant
TOIIW
$6.5K ﹤0.01%
1,250,000
– –
SRZNW icon
100
Surrozen Inc Warrant
SRZNW
$75.6K
$3.57K ﹤0.01%
166,666
– –
2 3
4
5 6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2024 Portfolio in Review

As of Q4 2024, Deerfield Management held 466 positions worth $5.28B, down 21% from $6.69B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $1.19B in Q4 2024, closing 360 positions and reducing 24 holdings. Its most notable exit was Kura Oncology, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Deerfield Management opened a new position in Legend Biotech worth $50.5M.

  • Deerfield Management's largest Q4 2024 buy was Legend Biotech: 1,551,718 shares worth $50.5M.
  • Deerfield Management added most to NewAmsterdam Pharma in Q4 2024, an estimated $72.5M increase.
  • Deerfield Management's biggest Q4 2024 reduction was Nuvalent, cutting an estimated $187M.
  • Deerfield Management fully exited Kura Oncology in Q4 2024, selling an estimated $106M.
  • Deerfield Management's ten largest holdings make up 54% of its $5.28B portfolio in Q4 2024.
  • Deerfield Management opened 23 new positions and closed 360 in Q4 2024.
  • Deerfield Management's portfolio value fell 21% quarter-over-quarter to $5.28B.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.